Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Redx Pharma is a drug discovery and development company.
Werewool develops a fiber development platform to create biodegradable fibers.
LimFlow SA is a venture-backed medical device company.
AFYREN is a green chemistry company that produces biobased, low-carbon carboxylic acids through sustainable fermentation technology.
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.
A French biotechnology company that uses precision fermentation to produce real dairy products, accessible to everyone.
Moon Surgical develops a new category of robotic surgery that enhances existing clinical practice with collaborative and adaptive robotics.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.
NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.
Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.
Actithera is a molecular radiotherapeutic company that develops radioligand therapies.
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.
We are making biology programmable to transform health and sustainability for the benefit of all.
Berry Street offers treatment for disordered eating, heart health, PCOD, liver disease, women's health, sports nutrition, and diabetes.
Leucid is progressing novel cart therapies that produce a better and more durable response.
Freya Biosciences is a clinical-stage women's health company pioneering a new class of microbial immunotherapies.
Elicit Plant is an agro-biotech company thatfocuses on enhancing the resilience of crops under drought conditions through natural processes.
Sofinnova Partners has invested in 148 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Pharmaceutical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Hemab received $157.0M in a Series C round. Sofinnova Partners's total known invested capital is $5.4B.
Sofinnova Partners's average investment size is $45.1M across its portfolio of 148 companies.
Recent Sofinnova Partners portfolio additions include Redx Pharma, Werewool, LimFlow SA, AFYREN, Alia Therapeutics. These companies were founded in 2020 or later.